New Sweet Triterpene Saponins from Albizia
J ournal of Natural Products, 2002, Vol. 65, No. 11 1641
f MeOH-H2O (60:40) f MeOH] to give six fractions [Fr. 1
(43.1 g), Fr. 2 (0.9 g), Fr. 3 (9.1 g), Fr. 4 (12.1 g), Fr. 5 (16.0 g),
and Fr. 6 (1.8 g)]. Fraction 3 (9.1 g) was subjected to normal-
phase silica gel column chromatography [30 g, CHCl3-MeOH-
H2O (15:3:1, lower layer f 6:4:1) f MeOH] to give albiziasa-
ponin A (1, 850 mg, 0.12%). Fraction 4 (200 mg) was purified
by HPLC [YMC-Pack Ph, 250 × 20 mm i.d., MeOH-1%
aqueous AcOH (70:30)] to furnish 1 (97 mg, 0.85%). Fraction
5 (16.0 g) was further separated by reversed-phase silica gel
column chromatography [480 g, MeOH-H2O (70:30) f MeOH]
to afford four fractions [Fr. 5-1 (2.6 g), Fr. 5-2 (6.0 g), Fr. 5-3
(2.2 g), and Fr. 5-4 (5.2 g)]. Fraction 5-2 (3.0 g) was purified
by HPLC [YMC-Pack ODS-A, 250 × 20 mm i.d., MeOH-1%
aqueous AcOH (70:30)] to give eight further fractions [Fr. 5-2-1
(213 mg), Fr. 5-2-2 (102 mg), Fr. 5-2-3 (24 mg), Fr. 5-2-4 (89
mg), Fr. 5-2-5 ()1, 1800 mg, 0.52%), Fr. 5-2-6 (339 mg), Fr.
5-2-7 (324 mg), and Fr. 5-2-8 (109 mg)]. Fraction 5-2-4 (89 mg)
was purified by HPLC [YMC-Pack ODS-A, 250 × 20 mm i.d.,
CH3CN-1% aqueous AcOH (35:75)] to furnish albiziasaponin
E (5, 56 mg, 0.016%). Fraction 5-2-6 (339 mg) was purified by
HPLC [YMC-Pack ODS-A, 250 × 20 mm i.d., CH3CN-1%
aqueous AcOH (35:75)] to afford albiziasaponins C (3, 24 mg,
0.007%) and D (4, 15 mg, 0.004%). Fraction 5-2-7 (324 mg)
was purified by HPLC [YMC-Pack ODS-A, 250 × 20 mm i.d.,
CH3CN-1% aqueous AcOH (40:60)] to give albiziasaponin A
monomethyl ester (1a , 40 mg, 0.012%) and 4 (59 mg, 0.017%).
Fraction 5-2-8 (109 mg) was purified by HPLC [YMC-Pack
ODS-A, 250 × 20 mm i.d., CH3CN-1% aqueous AcOH (40:
60)] to give licorice-saponin F3 (29 mg, 0.008%). Fraction 5-3
(1.8 g) was purified by HPLC [YMC-Pack ODS-A, 250 × 20
mm i.d., MeOH-1% aqueous AcOH (80:20)] to give Fr. 5-3-1
(134 mg), Fr. 5-3-2 (30 mg), Fr. 5-3-3 (79 mg), Fr. 5-3-4
[albiziasaponin B (2, 800 mg, 0.13%)], and Fr. 5-3-5 (757 mg).
Finally, fraction 5-3-1 (134 mg) was purified by HPLC [YMC-
Pack ODS-A, 250 × 20 mm i.d., MeOH-1% aqueous AcOH
(75:35)] to give yunganoside B1 (19 mg, 0.003%).
see Table 1; positive-ion FABMS m/z 993 [M + Na]+; negative-
ion FABMS m/z 969 [M - H]-, 823 [M - C6H11O4]-, 647 [M -
C12H19O10]-, 471 [M - C18H27O16]-; HRFABMS m/z 993.4696
(calcd for C48H74O20Na [M + Na]+, 993.4671).
Albizia sa p on in C (3): colorless fine crystals from CHCl3-
MeOH, mp 269-272 °C; [R]D24 -12.6° (c 0.10, MeOH); IR (KBr)
νmax 3453, 2926, 1765, 1632, 1078, 1048 cm-1; 1H NMR
(pyridine-d5, 500 MHz) δ 0.68, 0.82, 0.98, 1.18, 1.19, 1.46 (3H
each, all s, H3-25, 26, 28, 29, 27, and 23), 1.75 (3H, d, J ) 6.4
Hz, H-6′′′), 2.13 (1H, dd, J ) 6.7, 12.8 Hz, H-18), 3.42 (1H, dd,
J ) 4.6, 11.9 Hz, H-3), 3.33, 4.28 (1H each, both d-like, H2-
24), 4.15 (1H, br d, J ) ca. 6 Hz, H-22), 4.97 (1H, d, J ) 7.6
Hz, H-1′), 5.01 (1H, d, J ) 7.6 Hz, H-1′′′′), 5.12 (1H, br s, H-12),
5.75 (1H, d, J ) 7.6 Hz, H-1′′), 6.33 (1H, br s, H-1′′′); 13C NMR
data, see Table 1; positive-ion FABMS m/z 1139 [M + Na]+;
negative-ion FABMS m/z 1115 [M - H]-, 969 [M - C6H11O4]-,
953 [M - C6H11O5]-, 645 [M - C18H31O14]-; HRFABMS m/z
1139.5261 (calcd for C54H84O24Na [M + Na]+, 1139.5250).
Albizia sa p on in D (4): colorless fine crystals from CHCl3-
MeOH, mp 238-240 °C; [R]D24 -13.3° (c 0.10, MeOH); IR (KBr)
νmax 3445, 2930, 1765, 1655, 1078, 1043 cm-1 1H NMR
;
(pyridine-d5, 500 MHz) δ 0.68, 0.82, 0.98, 1.19, 1.24, 1.49 (3H
each, all s, H3-25, 26, 28, 29, 27, and 23), 1.74 (3H, d, J ) 6.1
Hz, H-6′′′), 2.13 (1H, dd, J ) 6.4, 13.1 Hz, H-18), 3.42 (1H, dd,
J ) 4.3, 11.6 Hz, H-3), 3.33, 4.28 (1H each, both d-like, H2-
24), 4.16 (1H, br d, J ) ca. 6 Hz, H-22), 4.86 (1H, d, J ) 7.3
Hz, H-1′′′′), 4.97 (1H, d, J ) 8.0 Hz, H-1′), 5.12 (1H, br s, H-12),
5.74 (1H, d, J ) 7.6 Hz, H-1′′), 6.24 (1H, br s, H-1′′′); 13C NMR
data, see Table 1; positive-ion FABMS m/z 1087 [M + H]+,
1109 [M + Na]+; negative-ion FABMS m/z 1085 [M - H]-, 953
[M - C5H9O4]-, 939 [M - C6H11O4]-, 645 [M - C17H29O13]-;
HRFABMS m/z 1109.5157 (calcd for C53H82O23Na [M + Na]+,
1109.5145).
Albizia sa p on in E (5): colorless fine crystals from CHCl3-
MeOH, mp 240-242 °C; [R]D24 -11.4° (c 0.10, MeOH); IR (KBr)
νmax 3445, 2933, 1752, 1655, 1078, 1047 cm-1; 1H NMR
(pyridine-d5, 500 MHz) δ 0.73, 0.83, 0.97, 1.18, 1.21, 1.49 (3H
each, all s, H3-25, 26, 28, 29, 27, and 23), 1.75 (3H, d, J ) 6.4
Hz, H-6′′′), 2.13 (1H, dd, J ) 6.4, 13.1 Hz, H-18), 3.43 (1H, dd,
J ) 4.3, 11.6 Hz, H-3), 3.53, 4.40 (1H each, both d-like, H2-
24), 4.15 (1H, br d, J ) ca. 7 Hz, H-22), 4.89 (1H, d, J ) 7.3
Hz, H-1′′′′), 5.03 (1H, d, J ) 7.6 Hz, H-1′), 5.12 (1H, br s, H-12),
5.89 (1H, d, J ) 7.6 Hz, H-1′′), 6.15 (1H, br s, H-1′′′); 13C NMR
data, see Table 1; positive-ion FABMS m/z 1101 [M + H]+,
1123 [M + Na]+; negative-ion FABMS m/z 1099 [M - H]-, 967
[M - C5H9O4]-, 953 [M - C6H11O4]-; HRFABMS m/z 1123.4954
(calcd for C53H80O24Na [M + Na]+, 1123.4937).
Acid Hyd r olysis of Albizia sa p on in s A (1), B (2), C (3),
D (4), a n d E (5). A solution of 1-5 (5 mg each) in 5% aqueous
H2SO4-1,4-dioxane (1:1, 2 mL) was heated under reflux for 1
h. After cooling, the reaction mixture was neutralized with
Amberlite IRA-400 (OH- form) and the resin was removed by
filtration. After removal of the solvent from the filtrate under
reduced pressure, the residue was transferred to a Sep-Pak
C18 cartridge with H2O and MeOH. The H2O eluate was
concentrated in vacuo to give a residue, which was treated with
L-cysteine methyl ester hydrochloride (4 mg) in pyridine (0.5
mL) at 60 °C for 1 h. After the reaction, the solution was
treated with N,O-bis(trimethylsilyl)trifluoroacetamide (0.2 mL)
at 60 °C for 1 h. The supernatant of the reaction mixture was
then subjected to GLC analysis to identify the derivatives of
D-glucuronic acid (i) and L-rhamnose (ii) from 1-5; D-glucose
(iii) from 3 and 4; and D-xylose (iv) from 4 and 5. GLC
conditions: Supelco STB-1, 30 m × 0.25 mm (i.d.) capillary
column; injector temperature, 230 °C; detector temperature,
230 °C; column temperature, 230 °C; He flow rate, 15 mL/
min; tR: (i) 26.4 min, (ii) 15.4 min, (iii) 24.2 min, and (iv) 13.8
min.
Licorice-saponin F34 and yunganoside B1 were identified
5
by comparison of their physical data ([R]D, IR, 1H NMR, 13C
NMR, MS) with reported values.
Albizia sa p on in A (1): colorless fine crystals from CHCl3-
MeOH, mp 226-229 °C; [R]D24 -28.2° (c 0.10, MeOH); IR (KBr)
1
νmax 3453, 2940, 1760, 1640, 1047 cm-1; H NMR (pyridine-
d5, 500 MHz) δ 0.71, 0.82, 0.98, 1.20, 1.22, 1.51 (3H each, all
s, H3-25, 26, 28, 29, 27, and 23), 1.81 (3H, d, J ) 6.4 Hz, H-6′′′),
2.13 (1H, dd, J ) 6.4, 13.3 Hz, H-18), 3.45 (1H, dd, J ) 4.3,
11.6 Hz, H-3), 3.48, 4.40 (1H each, both d, J ) 11.6 Hz, H2-
24), 4.20 (1H, br d, J ) ca. 6 Hz, H-22), 5.06 (1H, d, J ) 7.6
Hz, H-1′), 5.13 (1H, br s, H-12) 5.87 (1H, d, J ) 7.6 Hz, H-1′′),
6.27 (1H, br s, H-1′′′); 13C NMR data, see Table 1; positive-ion
FABMS m/z 969 [M + H]+, 991 [M + Na]+; negative-ion
FABMS m/z 967 [M - H]-, 821 [M - C6H11O4]-, 645 [M -
C
12H19O10]-; HRFABMS m/z 969.4724 (calcd for C48H73O20 [M
+ H]+, 969.4695), 991.4543 (calcd for C48H72O20Na [M + Na]+,
991.4515).
Albizia sa p on in A m on om eth yl ester (1a ): colorless fine
crystals from CHCl3-MeOH, mp 209-212 °C; [R]D25 -16.6° (c
0.86, MeOH); 1H NMR (pyridine-d5, 500 MHz) δ 0.79, 0.84,
0.97, 1.19, 1.20, 1.54 (3H each, all s, H3-25, 26, 28, 29, 27, and
23), 1.78 (3H, d, J ) 6.1 Hz, H-6′′′), 2.13 (1H, dd like, H-18),
3.45 (1H, dd, J ) 4.8, 11.9 Hz, H-3), 3.54, 4.43 (1H each, both
d like, H2-24), 3.77 (3H, s, -OCH3), 4.15 (1H, br d, J ) ca. 6
Hz, H-22), 5.03 (1H, d, J ) 7.4 Hz, H-1′), 5.13 (1H, br s, H-12)
5.87 (1H, d, J ) 7.7 Hz, H-1′′), 6.29 (1H, br s, H-1′′′); 13C NMR
data, see Table 1; positive-ion FABMS m/z 983 [M + H]+, 1005
[M + Na]+; negative-ion FABMS m/z 981 [M - H]-, 835 [M -
C6H11O4]-.
Albizia sa p on in B (2): colorless fine crystals from CHCl3-
MeOH, mp 220-223 °C; [R]D24 +4.6° (c 0.10, MeOH); IR (KBr)
1
νmax 3453, 2930, 1730, 1645, 1047 cm-1; H NMR (pyridine-
En zym a tic Hyd r olysis of Albizia sa p on in s A (1) a n d
C-E (3-5) To Affor d 6. A solution of 1 (20.0 mg) in 0.1 M
acetate buffer (pH 4.4, 2.0 mL) was treated with glycyrrhizinic
acid hydrolase (Maruzen Pharmaceutical Co., Ltd., Hiroshima,
J apan, 1.0 mL), and the mixture was stirred at 44 °C for 3 h.
After treatment of the reaction mixture with EtOH, the solvent
was evaporated to dryness under reduced pressure and the
d5, 500 MHz) δ 0.72, 0.88, 0.90, 1.31, 1.37, 1.52, (3H each, all
s, H3-25, 28, 26, 27, 29, and 23), 1.80 (3H, d, J ) 6.1 Hz, H-6′′′),
2.39 (1H, dd, J ) 3.1, 12.8 Hz, H-18), 3.45 (1H, dd, J ) 4.0,
12.8 Hz, H-3), 3.49, 4.39 (1H each, both d, J ) 11.6 Hz, H2-
24), 5.07 (1H, d, J ) 7.6 Hz, H-1′), 5.44 (1H, br s, H-12), 5.90
(1H, d, J ) 7.9 Hz, H-1′′), 6.31 (1H, br s, H-1′′′); 13C NMR data,